Regeneron Pharmaceuticals Inc Net Income per Employee (REGN), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Regeneron Pharmaceuticals Inc   (NASDAQ: REGN)
 

Regeneron Pharmaceuticals Inc Net Income per Employee

REGN's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 33.47% in the third quarter 2026, year on year to cumulative value of $4,817 million, and with 15,410 employees, Regeneron Pharmaceuticals Inc 's income per employee grew on trailing twelve month basis to $ 312,615. The income per employee at Regeneron Pharmaceuticals Inc ' was above the company average.
The Healthcare sector has seen employees of 32 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 455, from total ranking in previous quarter at 568.


What is Income per Employee Ratio?






REGN Net Income per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Net Income Change 33.47 % -6.81 % -10.08 % -7.97 % 8.91 %
Net Income per Employee (TTM) $ 312,615 280,902 287,047 292,336 297,080
REGN's Total Ranking # 455 # 568 # 428 # 418 # 415
Seq. Net Income Change 50.26 % 78.34 % -13.9 % -42.15 % 4.92 %


REGN Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 53
Overall Market # 455

Net Income per Employee Statistics
High Average Low
$ 524,030 $ 163,469 $ -14,391
(Dec 31 2021)   (Dec 31 2011)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Acadia Pharmaceuticals Inc   453,921.05 $ 362.229  Million 798 
Indivior Pharmaceuticals Inc   451,000.00 $ 451.000  Million 1,000 
Alector Inc   402,067.96 $ 41.413  Million 103 
Denali Therapeutics Inc   393,667.99 $ 198.015  Million 503 
Neurocrine Biosciences Inc   351,250.00 $ 702.500  Million 2,000 
Standard Biotools Inc   342,097.69 $ 133.076  Million 389 
Regeneron Pharmaceuticals Inc   312,615.18 $ 4,817.400  Million 15,410 
Kiniksa Pharmaceuticals International Plc  299,366.12 $ 109.568  Million 366 
Bristol myers Squibb Company  284,338.46 $ 9,241.000  Million 32,500 
Lantheus Holdings Inc   226,240.57 $ 269.905  Million 1,193 
Corcept Therapeutics Inc  221,410.96 $ 161.630  Million 730 
Abbvie Inc   181,508.77 $ 10,346.000  Million 57,000 
Intuitive Surgical Inc   174,578.46 $ 2,971.500  Million 17,021 
Caredx Inc   168,142.48 $ 128.629  Million 765 
Transmedics Group Inc   162,904.23 $ 146.288  Million 898 


Date modified: 2026-10-31T17:28:33+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.